3186 results for «817»

Filter By

3186 results

The uncompromised hemodynamics of the ALLEGRA transfemoral TAVI system in clinical practice

21 Nov 2021 – From PCR London Valves 2021

Join Raúl Moreno, Julian Widder and Mathias Wolfrum  if you want to learn about a single-centre experience of their first 100 patients treated with the ALLEGRA, and to see clinical outcome data on over 250 cases treated with ALLEGRA from a European multicentre registry.

The uncompromised hemodynamics

Is image fusion needed or too complex for standard transcatheter edge-to-edge repair?

21 Nov 2021 – From PCR London Valves 2021

Join Covadonga Fernandez-Golfin, Roberto Corti and Patric Biaggi if you want to learn about the benefits of image fusion and discover some tips and tricks on how to make image fusion easy and not complex in transcatheter edge-to-edge-repair.

Is image fusion needed

Best cases and research

08 Oct 2021 – From AICT-AsiaPCR 2021

Watch this session to discover the best cases and research unveiled at AICT-AsiaPCR 2021: "Positive remodelling of coronary arteries on computed tomography coronary angiogram", "Investigation of heavy metals in coronary artery tissues in autopsy cases", "DEB vs DES in the main vessel for the treatment of...

Best cases and research

Wrap-up of the day

08 Oct 2021 – From AICT-AsiaPCR 2021

Wrap-up of the day

The impact of the first transcatheter heart valve on the lifetime management of patients with aortic stenosis

18 May 2022 – From EUROPCR 2022

This session from EuroPCR 2022 will help you understand how the first bioprosthetic aortic valve may affect long-term outcomes of patients with aortic stenosis. Learn how to optimise their lifetime management and how to refine procedural steps during TAVI.

The impact of the first transcatheter heart valve on the lifetime management of patients with aortic stenosis

Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions

08 Jan 2025

In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.

Author

Bruno Scheller
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
Didn’t find what you were looking for?